MR
Institute of Biomedical Research Corp.
MRES · OTC
$0.00 -8.82% (-$0.00)
1M +158.33%
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
50 /100
Moderate Beta -0.64x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MRES
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Drasko D. Pekovic
Employees
5
Headquarters
Podgorica